HIF1A and invasive breast carcinoma: Taking breast cancer again as an example, Dales and colleagues carried out anti-HIF-1α immunohistochemistry on frozen sections of 745 breast cancer samples and found that approximately 25–40% of all invasive breast cancer samples are hypoxic4.